Avenue Therapeutics
Stock Forecast, Prediction & Price Target
Avenue Therapeutics Financial Estimates
Avenue Therapeutics Revenue Estimates
Avenue Therapeutics EBITDA Estimates
Avenue Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $258.96M Low: $258.96M High: $258.96M avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $46.50M Low: $46.50M High: $46.50M avg. 0% |
Net Income
% change YoY
| $-3.72M N/A | $2.04M 154.99% | $-10.37M -606.68% | Avg: $-15.2M Low: $-470.26K High: $-470.26K avg. -46.47% | Avg: $-17.36M Low: $-402.48K High: $-402.48K avg. -14.21% | Avg: $-480.15K Low: $-480.15K High: $-480.15K avg. 97.23% | Avg: $196.29K Low: $196.29K High: $196.29K avg. 140.88% |
EBITDA
% change YoY
| $-3.73M N/A | $-8.02M -114.63% | $4.05M 150.50% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$3.29 N/A | $0.94 128.57% | -$73.6 -7929.78% | Avg: -$3.33 Low: -$3.33 High: -$3.33 avg. 95.47% | Avg: -$2.85 Low: -$2.85 High: -$2.85 avg. 14.41% | Avg: -$3.4 Low: -$3.4 High: -$3.4 avg. -19.29% | Avg: $1.39 Low: $1.39 High: $1.39 avg. 140.88% |
Operating Expenses
% change YoY
| $3.73M N/A | $8.04M 115.16% | $14.54M 80.77% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Avenue Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 44.35% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -470.26K, average is -15.2M and high is -470.26K.
What is Avenue Therapeutics stock revenue growth forecast?
We have gathered data from 1 analysts. Their low revenue estimate is $258.96M, average is $258.96M and high is $258.96M.
What is Avenue Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 57.86% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$3.33, average is -$3.33 and high is $-3.33.
What is the best performing analyst?
In the last twelve months analysts have been covering Avenue Therapeutics stock. The most successful analyst is Jason McCarthy.